Literatur
- 1
Agboola O, Benoit B, Cross P. et al .
Prognostic factors derived from recursive partition analysis (RPA) of radiation therapy
oncology group (RTOG) brain metastases trials applied to surgically resected and irradiated
brain metastatic cases.
Int J Radiat Oncol Biol Phys.
1998;
42
155-159
- 2
Andrews D W, Scott C B, Sperduto P W. et al .
Whole brain radiation therapy with or without stereotactic radiosurgery boost for
patients with one to three brain metastases: phase III results of the RTOG 9508 randomised
trial.
Lancet.
2004;
363
1665-1672
- 3
Antonadou D, Paraskevaidis M, Sarris G. et al .
Phase II randomized trial of temozolomide and concurrent radiotherapy in patients
with brain metastases.
J Clin Oncol.
2002;
20
3644-3650
- 4
Aoyama H, Shirato H, Nakagawa K. et al .
Interim report of the JROSG-99 - 1 multi-institutional randomized trial, comparing
radiosurgery alone vs. radiosurgery plus whole brain irradiation for 1 - 4 metastases
(Presentation data).
Proc ASCO.
2004;
23
108
- 5
Arbit E, Wronski M, Burt M. et al .
The treatment of patients with recurrent brain metastases - A retrospective analysis
of 109 patients with nonsmall cell lung cancer.
Cancer.
1995;
76
765-773
- 6
Barker F G.
Craniotomy for the resection of metastatic brain tumors in the US, 1988 - 2000.
Cancer.
2004;
100
999-1007
- 7
van den Bent M J.
The role of chemotherapy in brain metastases.
Eur J Cancer.
2003;
39
2214-2220
- 8
Bezjak A, Adam J, Barton R. et al .
Symptom response after palliative radiotherapy for patients with brain metastases.
Eur J Cancer.
2002;
38
487-496
- 9
Bindal R K, Sawaya R, Leavens M E. et al .
Surgical treatment of multiple brain metastases.
J Neurosurg.
1993;
79
210-216
- 10
Bindal A K, Bindal R K, Hess K R. et al .
Surgery versus radiosurgery in the treatment of brain metastasis.
J Neurosurg.
1996;
84
748-754
- 11
Bonnette P, Puyo P, Gabriel C. et al .
Surgical management of non-small cell lung cancer with synchronous brain metastases.
Chest.
2001;
119
1469-1475
- 12
Bunn P A, Witta S E, Kavanagh B.
Brain metastases in small cell lung cancer - The Quan/Videtic/Suh article reviewed.
Oncology (Huntingt).
2004;
18
974-979
- 13
Chen C, Gaspar L E.
Brain metastases in small cell lung cancer - The Quan/Videtic/ Suh article reviewed.
Oncology (Huntingt).
2004;
18
980-887
- 14
Cortes J, Rodriguez J, Aramendia J M. et al .
Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell
lung cancer.
Oncology.
2003;
64
28-35
- 15
Cotto C, Berille J, Souquet P J. et al .
A phase II trial of fotemustine and cisplatin in central nervous system metastases
from non-small cell lung cancer.
Eur J Cancer.
1996;
32A
69-71
- 16
French L A, Galicich J H.
The use of steroids for control of cerebral edema.
Clin Neurosurg.
1964;
10
212-223
- 17
Furuse K, Kamimori T, Kawahara M. et al .
A pilot study of concurrent whole-brain radiotherapy and chemotherapy combined with
cisplatin, vindesine and mitomycin in non-small-cell lung cancer with brain metastasis.
Br J Cancer.
1997;
75
614-618
- 18
Gaspar L, Scott C, Rotman M. et al .
Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy
oncology group (RTOG) brain metastases trials.
Int J Radiat Oncol Biol Phys.
1997;
37
745-751
- 19
Glantz M J, Cole B F, Forsyth P A. et al .
Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain
tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology.
Neurology.
2000;
54
1886-1893
- 20
Guerrieri M, Wong K, Ryan G. et al .
A randomised phase III study of palliative radiation with concomitant carboplatin
for brain metastases from non-small cell carcinoma of the lung.
Lung Cancer.
2004;
46
107-111
- 21
Hellwig D, Ukena D, Paulsen F. et al .
Metaanalyse zum Stellenwert der Positronen-Emissionstomographie mit F-18-Fluorodesoxyglukose
(PDG-PET) bei Lungentumoren.
Pneumologie.
2001;
55
367-377
- 22
Herth F JF, Eberhardt R.
Screeningprogramme für das Bronchialkarzinom - Contra.
Dtsch Med Wochenschr.
2005;
130
467
- 23
Kelly K, Bunn Jr P A.
Is it time to reevaluate our approach to the treatment of brain metastases in patients
with non-small cell lung cancer?.
Lung Cancer.
1998;
20
85-91
- 24
Korfel A, Oehm C, von Pawel J. et al .
Response to topotecan of symptomatic brain metastases of small-cell lung cancer also
after whole-brain irradiation: a multicentre phase II study.
Eur J Cancer.
2002;
38
1724-1729
- 25
Komarnicky L T, Phillips T L, Martz K. et al .
A randomized phase III protocol for the evaluation of misonidazole combined with radiation
in the treatment of patients with brain metastases (RTOG-7916).
Int J Radiat Oncol Biol Phys.
1991;
20
53-58S>
- 26
Kristjansen P E, Soelberg Sorensen P, Skov H ansen M. et al .
Prospective evaluation of the effect on initial brain metastases from small cell lung
cancer of platinum-etoposide based induction chemotherapy followed by an alternating
multidrug regimen.
Ann Oncol.
1993;
4
579-583
- 27
Lagerwaard F J, Levendag P C, Nowak P JCM. et al .
Identification of prognostic factors in patients with brain metastases: A review of
1292 patients.
Int J Radiat Oncol Biol Phys.
1999;
43
795-803
- 28
Langer C J, Mehta M P.
Current management of brain metastases, with a focus on systemic options.
J Clin Oncol.
2005;
23
6207-6219
- 29
Minotti V, Crino L, Meacci M L. et al .
Chemotherapy with cisplatin and teniposide for cerebral metastases in non-small cell
lung cancer.
Lung Cancer.
1998;
20
93-98
- 30
Mintz A H, Kestle J, Rathbone M P. et al .
A Randomized Trial to Assess the Efficacy of Surgery in Addition to Radioctherapy
in Patients with a Single Cerebral Metastasis.
Cancer.
1996;
78
1470-1476
- 31
Muacevic A, Kreth F W, Horstmann G A. et al .
Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of
solitary cerebral metastases of small diameter.
J Neurosurg.
1999;
91
35-43
- 32
Murray K J, Scott C, Greenberg H M. et al .
A randomized phase III study of accelerated hyperfractionation versus standard in
patients with unresected brain metastases: A report of the Radiation Therapy Oncology
Group (RTOG) 9104.
Int J Radiat Oncol Biol Phys.
1997;
39
571-574
- 33
O’Neill B P, Iturria N J, Link M J. et al .
A comparison of surgical resection and stereotactic radiosurgery in the treatment
of solitary brain metastases.
Int J Radiat Oncol Biol Phys.
2003;
55
1169-1176
- 34
Patchell R A, Tibbs P A, Walsh J W. et al .
A randomized trial of surgery in the treatment of single metastases to the brain.
N Engl J Med.
1990;
322
494-500
- 35
Patchell R A, Tibbs P A, Regine W F. et al .
Postoperative radiotherapy in the treatment of single metastases to the brain - A
randomized trial.
JAMA.
1998;
280
1485-1489
- 36
Pfister D G, Johnson D H, Azzoli C G. et al .
American Society of Clinical Oncology treatment of unresectable non-small-cell lung
cancer guideline: update 2003.
J Clin Oncol.
2004;
22
330-353
- 37
Postmus P E, Haaxma-Reiche H, Smit E F. et al .
Treatment of brain metastases of small-cell lung cancer: comparing teniposide and
teniposide with whole-brain radiotherapy-a phase III study of the European Organization
for the Research and Treatment of Cancer Lung Cancer Cooperative Group.
J Clin Oncol.
2000;
18
3400-3408
- 38
Quan A L, Videtic G MM, Suh J H.
Brain metastases in small cell lung cancer.
Oncology (Huntingt).
2004;
18
961-972
- 39
Sawaya R, Ligon B L, Bindal A K. et al .
Surgical treatment of metastatic brain tumors.
J Neurooncol.
1996;
27
269-277
- 40
Schmidt B, Liebers U, Witt C.
Screeningprogramme für das Bronchialkarzinom - Pro.
Dtsch Med Wochenschr.
2005;
130
466
- 41
Schouten L J, Rutten J, Huveneers H AM. et al .
Incidence of Brain Metastases in a Cohort of Patients with Carcinoma of the Breast,
Colon, Kidney, and Lung and Melanoma.
Cancer.
2002;
94
2698-2705
- 42
Serizawa T, Ono J, Iichi T. et al .
Gamma knife radiosurgery for metastatic brain tumors from lung cancer: a comparison
between small cell and non-small cell carcinoma.
J Neurosurg.
2002;
97
484-488
- 43
Seute T, Leffers P, ten Velde G P. et al .
Neurologic disorders in 432 consecutive patients with small cell lung carcinoma.
Cancer.
2004;
100
801-806
- 44
Shaw E, Scott C, Souhami L. et al .
Single dose radiosurgical treatment of recurrent previously irradiated primary brain
tumors and brain metastases: final report of RTOG protocol 90 - 05.
Int J Radiat Oncol Biol Phys.
2000;
47
291-298
- 45
Sheehan J P, Sun M H, Kondziolka D. et al .
Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term
outcomes and prognostic factors influencing patient survival time and local tumor
control.
J Neurosurg.
2002;
97
1276-1281
- 46
Simon G R, Wagner H.
American College of Chest Physicians: Small cell lung cancer.
Chest.
2003;
123 (Suppl 1)
259S-271S
- 47
Sneed P K, Suh J H, Goetsch S J. et al .
A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain
radiotherapy as the initial management of brain metastases.
Int J Radiat Oncol Biol Phys.
2002;
53
519-526
- 48
Thomas M, Gatzemeier U, Goerg R. et al .
Empfehlungen zur Diagnostik des Bronchialkarzinoms.
Pneumologie.
2000;
54
361-371
- 49
Twelves C J, Souhami R L, Harper P G. et al .
The response of cerebral metastases in small cell lung cancer to systemic chemotherapy.
Br J Cancer.
1990;
61
147-150
- 50
Vecht C J, Haaxma-Reiche H, Noordijk E M. et al .
Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?.
Ann Neurol.
1993;
33
583-590
- 51
Verger E, Gil M, Yaya R. et al .
Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases:
a phase II randomized trial.
Int J Radiat Oncol Biol Phys.
2005;
61
185-191
- 52
Wong W W, Schild S E, Sawyer T E. et al .
Analysis of outcome in patients reirradiated for brain metastases.
Int J Radiat Oncol Biol Phys.
1996;
34
585-590
- 53
Yokoi K, Kamiya N, Matsuguma H. et al .
Detection of brain metastasis in potentially operable non-small cell lung cancer -
A comparison of CT and MRI.
Chest.
1999;
115
714-719
Dr. med. Daniel Binder
Medizinische Klinik m. S. Infektiologie und Pneumologie Charite - Universitätsmedizin
Berlin
Augustenburger Platz 1
13353 Berlin
Phone: 0 30/4 50 55 33 88
Fax: 0 30/4 50 55 39 11
Email: daniel.binder@charite.de
